Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buccal Misoprostol vs IV Oxytocin for Prevention of Postpartum Hemorrhage
NCT03676621Phase 4Completed
- Sponsor
- Assiut University
- Start
- Nov 2018
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Assiut University. Primary endpoint: Intraoperative and Postoperative Blood Loss at 24 hours. Started Nov 2018; status: completed.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT03676621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03676621.